Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Left ventricular hypertrophy in hypertension.

F G Dunn1, J M Burns, R S Hornung

  • 1Department of Medical Cardiology, Stobhill General Hospital, Glasgow, United Kingdom.

American Heart Journal
|July 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Winning hearts and minds: ECG reporting in the first seizure clinic.

BMC cardiovascular disorders·2021
Same author

Gambling and the Role of Resilience in an International Online Sample of Current and Ex-serving Military Personnel as Compared to the General Population.

Journal of gambling studies·2019
Same author

Unkind cuts.

Nursing standard (Royal College of Nursing (Great Britain) : 1987)·2016
Same author

Cardiorespiratory fitness and white matter integrity in Alzheimer's disease.

Brain imaging and behavior·2015
Same author

The Use of Donation After Cardiac Death Allografts Does Not Increase Recurrence of Hepatocellular Carcinoma.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Preparing Muscles for Diving: Age-Related Changes in Muscle Metabolic Profiles in Harp (Pagophilus groenlandicus) and Hooded (Cystophora cristata) Seals.

Physiological and biochemical zoology : PBZ·2015
Same journal

Stratified Medicine with Eplerenone for Myocardial Infarction or Injury and No obstructive Coronary Arteries: A Registry-Based Basket Trial.

American heart journal·2026
Same journal

Revised Lipid-Lowering Therapy Guidelines in a Nationally Representative Sample.

American heart journal·2026
Same journal

Cardiometabolic Health of Low- and Higher-Income Adults in the United States, 2009-2023.

American heart journal·2026
Same journal

Moving Beyond Technical Capability to Regulatory Integration for Digital Health Technology Devices-Brief Communication from the Cardiovascular Sciences Research Consortium.

American heart journal·2026
Same journal

THE SOCIETY OF CRITICAL CARE CARDIOLOGY - RATIONALE, BLUEPRINT, AND LESSONS LEARNED IN THE CREATION OF A NEW MULTIDISCIPLINARY PROFESSIONAL ORGANIZATION.

American heart journal·2026
Same journal

DOAC Score Among Patients Receiving Vitamin K Antagonists.

American heart journal·2026
See all related articles

Left ventricular hypertrophy (LVH) is a significant risk factor for cardiovascular disease in hypertensive patients. Antihypertensive drugs, including nicardipine, can cause LVH regression, but long-term benefits require further study.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Cardiovascular Disease

Background:

  • Left ventricular hypertrophy (LVH) is an independent risk factor for cardiovascular disease.
  • Hypertension is a major cause of LVH, increasing the risk of coronary artery disease and myocardial ischemia.
  • Echocardiography has improved the diagnosis of LVH.

Purpose of the Study:

  • To understand the interrelationships between hypertension and LVH.
  • To review the mechanisms of sudden death in patients with LVH.
  • To assess the efficacy of antihypertensive drugs in LVH regression.

Main Methods:

  • Review of recent advances in echocardiography for LVH diagnosis.
  • Analysis of studies on the relationship between hypertension, LVH, and cardiovascular events.

Related Experiment Videos

  • Evaluation of data on antihypertensive drug effects on LVH regression.

    • Main Results:

    • LVH is a critical independent risk factor for cardiovascular disease, particularly in hypertensive individuals.
    • The hypertrophied left ventricle is susceptible to myocardial ischemia.
    • Several antihypertensive drugs, including beta-blockers, ACE inhibitors, and nicardipine, promote LVH regression without impairing left ventricular function.

    Conclusions:

    • Understanding the link between hypertension and LVH is crucial for cardiovascular risk management.
    • LVH regression is achievable with certain antihypertensive medications.
    • Further research is necessary to determine the long-term clinical benefits of LVH regression.